Platelet-Activating Factor Antagonist Therapy for Airway Disorders

The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis

Best Practice & Research Clinical Gastroenterology ◽

10.1053/bega.1999.0030 ◽

1999 ◽

Vol 13 (2) ◽

pp. 357-364 ◽

Cited By ~ 11

Author(s):

C.W. Imrie ◽

C.J. McKay

Keyword(s):

Acute Pancreatitis ◽

Severe Acute Pancreatitis ◽

Platelet Activating Factor ◽

Antagonist Therapy ◽

Factor Antagonist

Download Full-text

Der Platelet-Activating Factor Antagonist WEB-2170 hemmt die Lipopolysaccharid-induzierte vorzeitige Reifung der uterinen Zervix

Zeitschrift für Geburtshilfe und Neonatologie ◽

10.1055/s-2003-818150 ◽

2004 ◽

Vol 207 (S 2) ◽

Author(s):

H Maul ◽

J Weichert ◽

HH Günter ◽

L Shi ◽

RE Garfield ◽

...

Keyword(s):

Platelet Activating Factor ◽

Factor Antagonist

Download Full-text

Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist

Journal of the American College of Cardiology ◽

10.1016/0735-1097(90)90330-r ◽

1990 ◽

Vol 16 (7) ◽

pp. 1750-1759 ◽

Cited By ~ 2

Author(s):

Erwin Schröder ◽

Hubert Pouleur ◽

Henri Van Mechelen ◽

André Keyeux ◽

Juan Raigoso ◽

...

Keyword(s):

Vascular Resistance ◽

Platelet Activating Factor ◽

Low Flow ◽

Demand Model ◽

High Demand ◽

Factor Antagonist ◽

Web 2086

Download Full-text

Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

Lipids ◽

10.1007/bf02536558 ◽

1991 ◽

Vol 26 (12) ◽

pp. 1324-1328 ◽

Cited By ~ 6

Author(s):

Oscar F. Pavão dos Santos ◽

Mirian A. Boim ◽

Elivo J. G. Barros ◽

Eduardo Pirotzky ◽

Pierre Braquet ◽

...

Keyword(s):

Platelet Activating Factor ◽

Factor Antagonist

Download Full-text

The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/ajrccm.149.5.8173754 ◽

1994 ◽

Vol 149 (5) ◽

pp. 1142-1148 ◽

Cited By ~ 65

Author(s):

D P Spence ◽

S L Johnston ◽

P M Calverley ◽

P Dhillon ◽

C Higgins ◽

...

Keyword(s):

Platelet Activating Factor ◽

Orally Active ◽

Factor Antagonist ◽

Web 2086

Download Full-text

Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/0960-894x(95)00088-b ◽

1995 ◽

Vol 5 (6) ◽

pp. 643-648 ◽

Cited By ~ 2

Author(s):

Md. Sajjat Hussoin ◽

Xiong Cai ◽

Ralph T. Scannell ◽

David Yaeger ◽

David B. Killian ◽

...

Keyword(s):

Platelet Activating Factor ◽

Lipoxygenase Inhibitor ◽

Factor Antagonist

Download Full-text

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.046 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S036-S036 ◽

Cited By ~ 5

Author(s):

D Lukin ◽

A Weiss ◽

S Aniwan ◽

S Kadire ◽

G Tran ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Propensity Score ◽

Bowel Disease ◽

Safety Profile ◽

Tumour Necrosis ◽

Antagonist Therapy ◽

Inflammatory Bowel ◽

Comparative Safety ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

Determination of the platelet activating factor antagonist 6-(2-chlorophenyl)-9-[(4-methoxyphenyl)thiocarbamoyl]-1-methyl-7,8,9,10-tetrahydro-4H-pyrido[4′,3′-4,5]-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4] diazepine in human plasma by liquid chromatography—thermospray mass spectrometry

Journal of Chromatography B Biomedical Sciences and Applications ◽

10.1016/0378-4347(94)80090-1 ◽

1994 ◽

Vol 657 (1) ◽

pp. 214-218

Author(s):

C. Celma

Keyword(s):

Mass Spectrometry ◽

Liquid Chromatography ◽

Human Plasma ◽

Platelet Activating Factor ◽

Thermospray Mass Spectrometry ◽

Factor Antagonist

Download Full-text

A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.90.6.2537 ◽

1993 ◽

Vol 90 (6) ◽

pp. 2537-2541 ◽

Cited By ~ 22

Author(s):

D. Weissman ◽

G. Poli ◽

A. Bousseau ◽

A. S. Fauci

Keyword(s):

Human Immunodeficiency Virus ◽

Platelet Activating Factor ◽

Immunodeficiency Virus ◽

Virus Expression ◽

Factor Antagonist ◽

Promonocytic Cells

Download Full-text

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute

Gut ◽

10.1136/gut.48.1.62 ◽

2001 ◽

Vol 48 (1) ◽

pp. 62-69 ◽

Cited By ~ 224

Author(s):

C D Johnson

Keyword(s):

Organ Failure ◽

Platelet Activating Factor ◽

Controlled Study ◽

Double Blind ◽

Treatment And Prevention ◽

Factor Antagonist

Download Full-text